Written before stock split
This narrative hasn't been updated since the stock split on 3 Aug 2026. The author has been notified to update.
Lexaria BioscienceLEXX
Fair Value
US$5.55
Share price26 Jan
US$11.27103.1% overvalued intrinsic discount
1Y-5.23%
7D24.67%
Lexaria Bioscience's Breakthrough with DehydraTECH to Revolutionize Drug Delivery
IN
Author hasn't set their bio yet
Published
26 Jan 26
Views
207
Not Invested